tDCS for older teens and adults with lazy eye
Part of Brain & nervous system, Eyes & vision clinical trials.
This study tests a gentle brain stimulation technique called transcranial direct current stimulation (tDCS) to see if it can help improve vision in older children and young adults with amblyopia (lazy eye).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 10 and 30 years old
- You have amblyopia (lazy eye) – either in one eye or both eyes
- You do not have other serious eye problems like cataracts or glaucoma
- You have not had eye surgery or a major eye injury in the past
- You are able to cooperate with eye exams and treatment
- You have not taken part in another experimental treatment in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new 3D vision therapy (like watching a 3D movie without special glasses) to treat lazy eye (amblyopia) in children aged 7 to 12. It may improve vision in the weaker eye by using a 3D display that trains both eyes to work together.
This study tests whether a non-invasive brain stimulation technique called tDCS (transcranial direct current stimulation) can help children with lazy eye (amblyopia) whose vision hasn't improved with traditional patching treatments. The goal is to see if stimulating the brain can boost the weak eye's vision.
This trial tests a new treatment for adults with lazy eye (amblyopia) that combines brain stimulation with a special vision game using augmented reality. The goal is to improve vision in the weaker eye.
This trial tests a gentle, noninvasive brain stimulation technique (called TMS) to see if it can improve vision in adults with lazy eye. It is a noninvasive approach that does not involve surgery or drugs.
This trial tests a new treatment for children aged 8 to 12 with lazy eye (amblyopia) who have stopped standard treatments. The goal is to see if this therapy can improve vision in the weaker eye.
This study focuses on adults with macular degeneration and aims to improve how well you can use your remaining vision. It uses learning and brain stimulation, so it may help you notice and use your vision more effectively.
Hear when a new Amblyopia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.